UnitedHealth Group Incorporated (UNH) — closed signal from December 21, 2025
Partial Published before the outcome was known, scored automatically when the window closed on March 21, 2026.
Predicted vs. what happened
What happened
Reached 78% of the predicted growth at its peak, without hitting the target.
The thesis — published December 21, 2025
UnitedHealth looks like a contrarian rebound: shares have fallen a lot and some signs show buying interest returning. The company announced 23 corrective actions and Optum Rx changed its reimbursement approach to try to improve profits into 2026. These steps increase the chance of stabilization, but audit and headline risk could still cause sharp drops. Treat this as a short-term bounce over the next 0-3 months.
Primary drivers
- Company plans and payer changes aim to fix profit margins
- Shares are far down, so a quick rebound is possible
- Healthcare firms tend to hold up when markets wobble
- Public audits and headlines could still push shares lower
How it played out
UNH: rebound fell short of the target
Lyra published UNH on 2025-12-21 at $327.42 as a short-term contrarian rebound. The thesis expected 12% growth to $366.71. It pointed to company plans, payer changes, a possible quick rebound after a large fall, healthcare defensiveness, and audit and headline risk that could still push shares lower.
Inside the window, UNH rose to a peak of $357.87 on 2026-01-23, a 9.3% gain. That stayed below the $366.71 target. It never got there. By 2026-03-21, the stock ended at $275.59. The thesis partly played out early, then missed the target and finished below the publication price.
What happened during the window
On 2026-01-27, UnitedHealth reported fourth-quarter revenue of $113.2 billion and gave 2026 revenue guidance of greater than $439 billion. MarketWatch reported that the stock fell after that update.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.